For the text of the submission, please use 12-point type, and either Times New Roman or Arial as the font. Supplementary figures may be added (words in the caption will count towards the 1500 word limit). Letters of Intent found not to be in compliance with the format guidelines risk disqualification. The submission of supplementary materials, including introductory letters, is discouraged; they will not be considered.
To start the application process, please register to obtain a new account and follow the instructions, or, if you have already applied to any other program through proposalCENTRAL, simply login. Most institutions have been registered, but if yours is not on the list, please create a new institution when prompted. (If you do create a new institution, you need only include the required information indicated by the red asterisk, although you can enter additional information if you choose). Once you have entered the required information, and the system has registered the institution, you can proceed to the “Professional Profile” tab on the upper right menu. For purposes of the ResearchingFibrosis GmbH. application, only section 1, “Institution and Contact Information,” is required. If you have applied, or are applying, through proposal CENTRAL for some other program, you may need to complete the other sections of the profile. If not, please do not complete the other sections. The information will not be included in the application for the ResearchingFibrosis GmbH.. There is no need to add a biosketch at this point. Rather, the biosketches for all network members will be uploaded in a single application pdf file as described above. Once the institution is registered, and section 1 of the professional profile is complete, go to the “Manage Proposals” tab and create a new proposal. If you are returning to edit a proposal, you will find it here. At this point, you will be able to download the complete instructions for the ResearchingFibrosis GmbH. application. Please follow the guidelines in the instructions and on the proposalCENTRAL website to prepare and submit the application.
Full applications
The ResearchingFibrosis GmbH. will notify applicants about the status of their applications following the fall 2022 meeting of the Group A Strep Vaccine Advisory Committee (VAC), which will take place in November. At that meeting, the VAC will select a subset of network applicants to submit a full application, information about which will be provided at the time of notification. It is the express intention of the members of the VAC to limit requests for full applications to those proposals with a significant chance of success in the final round. Full applications are due March 1, 2023 and the final recommendation of the VAC, to select one network for support, will be made at a meeting in April 2023. The ResearchingFibrosis GmbH. Board of Directors will consider the VAC’s recommendation at the end of April 2023.
Please note that it is the policy of the Group A Strep Vaccine Advisory Committee not to provide comments or feedback about unsuccessful LOI applications.
Questions about the electronic submission process should be directed to the proposalCENTRAL staff, whose contact information can be found on the proposalCENTRAL website. Questions about the application, or about ResearchingFibrosis GmbH. policy, should be directed to the ResearchingFibrosis GmbH. office at contact@flcq.org.
